C4 Therapeutics Inc (CCCC)
6.74
+0.31
(+4.82%)
USD |
NASDAQ |
May 03, 16:00
6.91
+0.17
(+2.52%)
After-Hours: 20:00
C4 Therapeutics Price to Book Value: 1.879 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.879 |
| May 02, 2024 | 1.792 |
| May 01, 2024 | 1.823 |
| April 30, 2024 | 1.756 |
| April 29, 2024 | 1.762 |
| April 26, 2024 | 1.720 |
| April 25, 2024 | 1.739 |
| April 24, 2024 | 1.803 |
| April 23, 2024 | 1.923 |
| April 22, 2024 | 1.912 |
| April 19, 2024 | 1.873 |
| April 18, 2024 | 1.926 |
| April 17, 2024 | 1.915 |
| April 16, 2024 | 1.904 |
| April 15, 2024 | 1.912 |
| April 12, 2024 | 2.065 |
| April 11, 2024 | 2.171 |
| April 10, 2024 | 2.152 |
| April 09, 2024 | 2.222 |
| April 08, 2024 | 2.135 |
| April 05, 2024 | 2.096 |
| April 04, 2024 | 2.152 |
| April 03, 2024 | 2.202 |
| April 02, 2024 | 2.141 |
| April 01, 2024 | 2.258 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.277 |
| March 27, 2024 | 2.244 |
| March 26, 2024 | 2.213 |
| March 25, 2024 | 2.288 |
| March 22, 2024 | 2.291 |
| March 21, 2024 | 2.428 |
| March 20, 2024 | 2.470 |
| March 19, 2024 | 2.422 |
| March 18, 2024 | 2.283 |
| March 15, 2024 | 2.489 |
| March 14, 2024 | 2.651 |
| March 13, 2024 | 2.991 |
| March 12, 2024 | 2.999 |
| March 11, 2024 | 2.963 |
| March 08, 2024 | 3.066 |
| March 07, 2024 | 2.949 |
| March 06, 2024 | 3.063 |
| March 05, 2024 | 2.927 |
| March 04, 2024 | 2.977 |
| March 01, 2024 | 3.063 |
| February 29, 2024 | 3.060 |
| February 28, 2024 | 3.052 |
| February 27, 2024 | 2.718 |
| February 26, 2024 | 2.651 |
| February 23, 2024 | 2.506 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2692
Minimum
Dec 11 2023
7.131
Maximum
Feb 10 2021
2.577
Average
1.532
Median
Price to Book Value Benchmarks
| Exact Sciences Corp | 3.582 |
| Alector Inc | 3.847 |
| CEL-SCI Corp | 6.955 |
| AIM ImmunoTech Inc | 2.116 |
| IGC Pharma Inc | 3.599 |
Price to Book Value Related Metrics
| PS Ratio | 16.12 |
| PEG Ratio | -1.323 |
| Price | 6.74 |
| Earnings Yield | -39.61% |
| Market Cap | 462.37M |
| PEGY Ratio | -1.323 |